Anika Therapeutics (69) | Human Resources (16)

Browse by Subcategory

Bonus & Incentive Agreements (6 contracts)
Compensation Agreements (1)
Consulting Agreements (1)
Employment Agreements (3)
Retention Agreements (4)
Separation Agreements (1)

Recent Contracts

Executive Retention Agreement, dated March 9, 2020, by and between Anika Therapeutics, Inc. and David Colleran (Filed With SEC on March 16, 2023)
Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 8, 2022) (Filed With SEC on June 10, 2022)
Anika Therapeutics, Inc. Non-Employee Director Compensation Policy (restated as of February 9, 2022) (Filed With SEC on March 11, 2022)
Employment Agreement dated as of April 23, 2020 between Anika Therapeutics, Inc. and Cheryl R. Blanchard (Filed With SEC on April 29, 2020)
Separation Agreement, effective July 8, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)
Consulting Agreement, effective July 5, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn, Ph.D (Filed With SEC on July 10, 2019)
Executive Retention Agreement, dated August 10, 2020, by and between Anika Therapeutics, Inc. and Michael Levitz (Filed With SEC on March 11, 2022)
Form of Notice of Grant of Incentive Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)
Form of Notice of Grant of Nonqualified Stock Option, including Terms and Conditions of Stock Option, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)
Form of Notice of Grant of Restricted Stock Units, including Terms and Conditions of Restricted Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)
Form of Notice of Grant of Deferred Stock Awards Units, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 5, 2021)
Form of Notice of Grant of Deferred Stock AwardsUnits, including Terms and Conditions of Deferred Stock Units, granted under Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (Filed With SEC on March 6, 2020)
Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated July 27, 2017, as amended March 8, 2018, by and between Anika Therapeutics, Inc. and Joseph G. Darling (Filed With SEC on April 12, 2019)
Amendment No. 2, dated April 9, 2019, to Employment Agreement, dated March 22, 2010, as amended December 8, 2010, by and between Anika Therapeutics, Inc. and Sylvia Cheung (Filed With SEC on April 12, 2019)
Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Thomas Finnerty (Filed With SEC on April 12, 2019)
Executive Retention Agreement, dated April 9, 2019, by and between Anika Therapeutics, Inc. and Edward S. Ahn (Filed With SEC on April 12, 2019)